0 Comentários
0 Compartilhamentos
2K Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market Opportunity Analysis Report"According to the latest report published by Data Bridge Market Research, the Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market The global dual GIP/ GLP-1 receptor agonists obesity drugs market size was valued at USD 4.75 billion in 2024 and is expected to reach USD 17.71 billion by 2032, at a CAGR of 17.85% during the forecast period The winning Dual GIP/ GLP-1 Receptor Agonists...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
GLP-1 Market: Innovation and Competitive LandscapeThe GLP-1 Market is expanding as therapeutic applications move beyond diabetes into obesity and cardiovascular disease. Valued at USD 52.82 billion in 2025, the GLP-1 Market is projected to reach USD 58.48 billion in 2026 and USD 133.92 billion by 2034, growing at a CAGR of 10.9% during the forecast period 2026–2034. Key players include AstraZeneca, Boehringer Ingelheim, D&D...0 Comentários 0 Compartilhamentos 17 Visualizações 0 Anterior
-
GLP-1-Friendly Nutrition Opportunity to Reach USD 5.5 Billion by 2034, Growing at a CAGR of 7.4% | OG AnalysisAccording to a new report published by OG Analysis, the global GLP-1 Companion Foods Market was valued at USD 3.1 billion in 2026 and is projected to reach USD 5.5 billion by 2034, expanding at a CAGR of 7.4% during the forecast period. The full report, including detailed segmentation, regional analysis, and competitive benchmarking, is available at:...0 Comentários 0 Compartilhamentos 699 Visualizações 0 Anterior